speaking of which, the management announced the completion of Pitt Hopkins in the quarterly update unlike the last one PMS which was a seperate Ann and they described it as a “groundbreaking trial”. I am wondering if this is deliberate to play it down as they sense from the open label the result may not be as good as PMS .I maybe reading too much into it and being paranoid but can’t stop thinking about this possibility
NEU Price at posting:
$18.65 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)